Skip to main content

Table 1 Comparison of basic characteristics of patients with OSA according to the presence of arteriosclerosis

From: Incremental values of AOPP, IL-6, and GDF15 for identifying arteriosclerosis in patients with obstructive sleep apnea

 

All patient

(n = 104)

OSA without arteriosclerosis

( n = 76)

OSA with arteriosclerosis

( n = 28)

p value

Clinical characteristics

 Age (yrs)

44.06 ± 10.37

44.37 ± 10.02

43.21 ± 11.41

0.62

 Male (n/%)

78 (75%)

58 (76%)

20 (71%)

0.61

 Height (cm)

172.12 ± 8.32

172.17 ± 7.94

171.96 ± 9.43

0.91

 Weight (kg)

83.94 ± 14.40

84.01 ± 14.19

83.61 ± 15.24

0.92

 Body mass index (kg/m2)

28.31 ± 4.33

28.33 ± 4.38

28.27 ± 4.28

0.95

 Systolic blood pressure (mmHg)

130.96 ± 14.31

124.25 ± 7.18

129.05 ± 13.93

0.02

 Diastolic blood pressure (mmHg)

86.54 ± 8.90

78.20 ± 6.04

87.82 ± 8.46

0.04

 Smoking (n/%)

57 (55%)

39 (51%)

18 (64%)

0.24

Laboratory examination

 Fasting blood glucose (mmol/L)

5.25 ± 0.60

5.27 ± 0.64

5.20 ± 0.45

0.61

 ALT (U/L)

21.00 (18.00–25.00)

21.50 (18.00–26.00)

21.00 (18.00–25.00)

0.91

 Creatine (μmol/L)

69.73 ± 11.59

68.65 ± 11.74

72.64 ± 10.84

0.12

 Urea (mmol/L)

4.87 ± 1.20

4.87 ± 1.22

4.87 ± 1.16

0.98

 Triglyceride (mmol/L)

1.15 (1.01–1.38)

1.13 (1.01–1.38)

1.23 (0.83–1.58)

0.70

 Total cholesterol (mmol/L)

4.43 ± 1.02

4.39 ± 0.96

4.52 ± 1.19

0.57

 HDLC (mmol/L)

1.24 ± 0.35

1.22 ± 0.34

1.26 ± 0.36

0.61

 LDLC (mmol/L)

2.45 ± 0.89

2.41 ± 0.77

2.54 ± 1.16

0.49

 AOPP (μmol/L)

56.60 (54.05–58.36)

56.35 (53.64–58.14)

57.89 (55.82–58.82)

0.01

 IL-6 (pg/mL)

58.58 (56.10–59.97)

58.32 (55.59–59.98)

59.44 (57.13–61.30)

0.03

 GDF15 (ng/L)

97.33 (93.35–100.76)

94.20 (92.21–98.66)

101.45 (99.33–103.68)

0.01

  1. Data are presented as mean ± SD, median (interquartile range), or frequency (percentages). Bold value means p < 0.05
  2. ALT alanine transaminase, HDLC high-density lipoprotein cholesterol, LDLC low-density lipoprotein cholesterol, AOPP advanced oxidation protein products, IL-6 interleukin-6, GDF15 growth differentiation factor 15